PATENT CLAIM ANALYSIS

Application Number: 15866871
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides compounds of Formula (I): a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Claim (Index 16):
A pharmaceutical composition comprising a compound according to  claim 7  and further comprising a dipeptidyl peptidase-IV (DPP4) inhibitor.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15123773', '15602515', '15618182', '15123791', '15617079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7929210912769439
- 35 USC 102 Novelty (BERT): 0.5584527446891545
- Combined Prediction Score: 0.7694742566181649
- Mean Citation Score: 379.091024
- Max Citation Score: 432.3285
- Similarity Product: 370.3533053910434

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test